Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-IV inhibitor

Details for Australian Patent Application No. 2009210641 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Pourkavoos, Nazaneen

Agent Spruson & Ferguson

Pub. Number AU-A-2009210641

PCT Pub. Number WO2009/099734

Priority 61/063,606 05.02.08 US

Filing date 15 January 2009

Wipo publication date 13 August 2009

International Classifications

A01N 37/52 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing groups, e.g. carboxylic acid amidines

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/099734 Priority application(s): WO2009/099734

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009210646-Implants for the vertebral column

2009210639-Method for the froth flotation of coal